Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

Infective Endocarditis Clinical Trial

Official title: Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

Status Recruiting

Clinical Trial Summary

As recommended in the Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (IE) patients with IE should be evaluated and managed by a multispecialty team including an cardiologist, infectious disease specialist, and cardiac surgeon. Our registry is a prospective, national registry of patients with IE. From January 2013 data from endocarditis board were prospectively recorded using standard definitions during the hospitalization. Patient demographics, clinical, laboratory, and imaging data at the time of IE diagnosis, as well as treatment outcomes were entered into the ER-UHC database.

Clinical Trial Description

The primary endpoint will be the 1 year all-cause mortality after treatment begins of IE. We will use 1 year all-cause mortality as the primary endpoint because it has been demonstrated that a period of at least 6 months is necessary to offset the early postoperative mortality related to valve surgery. We also looked at all-cause in-hospital mortality as a secondary endpoint. ;

Related Conditions & MeSH terms

• Endocarditis
• Endocarditis, Bacterial
• Infective Endocarditis

• NCT number: NCT02388893
• Study type: Observational [Patient Registry]
• Source: University of Cologne
• Contact: Guido Michels, Prof. Dr.
• Phone: ++49-221-478-32401
• Email: guido.michels@uk-koeln.de
• Status: Recruiting
• Start date: January 2013
• Completion date: December 2022